Intervention

Placebo Film

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting1

Common conditions11

Lead sponsors shown2

Clinical trials

3 shown

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar DisorderNCT05025605 · 2021-08-27

RECRUITING

Dexmedetomidine in the Treatment of Agitation Associated With SchizophreniaNCT04268303 · 2020-01-24

COMPLETED

Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIVNCT02579083 · 2016-01-01

COMPLETED

Common conditions

Schizophrenia2 Agitation1 Bipolar Disorder I1 Bipolar Disorder II1 Herpes Simplex Infections1 HIV1 Schizo Affective Disorder1 Schizo-Affective Disorder1 Schizoaffective Disorder1 Schizophreniform Disorders1 Schizophreniform; Schizophrenic1

Leading sponsors

BioXcel Therapeutics Inc2 KBio Inc1

Trial status mix

COMPLETED2

RECRUITING1

Phase mix

PHASE12

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.